Navidea Biopharmaceuticals, Inc. Made Headway

Fri 22 May 20 at 05:30 PM
Navidea Biopharmaceuticals, Inc. Made Headway

Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT) soared at $2.43, a gain of 91.3%. The stock got featured on our News Catalysts scanner on Fri 22 May 20 at 01:19 PM in the 'MISCELLANEOUS' category. From Thu 07 May 20, the stock recorded 40.00% Up Days and 54.55% Green Days

About Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT)

Navidea Biopharmaceuticals Inc is a biotechnology company engaged in precision medicine. Its products are designed to assist in the identification of undetected diseases and develop treatment for cancer, autoimmune conditions, and inflammatory diseases.

Share